On CNET: The Apple notebook guessing game

BNET Business Network:
BNET |
TechRepublic |
ZDNet

Find Articles in:: all; Business; Reference; Technology; News; Sports; Health; Autos; Arts; Home & Garden

Featured White Papers

PCI DSS therapy for the smaller retailer (McAfee)
Oct. 14th: Simplified IT with Software-as-a-Service (SaaS) (ZDNet)
Choosing the best CRM for your organization (Oracle)

Content provided in partnership with

Technology Industry

Industry: Email Alert RSS Feed

United Therapeutics Corp

BT Catalyst, May, 2003

United Therapeutics Corp. (Nasdaq: UTHR), with offices in Research Triangle Park, was recently issued two patents by the U.S. Patent and Trademark Office that broaden the company's patent protection for its lead drug Remodulin. Patent No. 6,521,212 relates to the method of treating peripheral vascular disease through the administration of Remodulin by inhalation, and Patent No.

Most Popular: 3 Questions No Job Seeker Ever Wants To Be Asked?; The Five Worst Jobs In HR; SWOT Analysis - To Make Your Business More Profitable; Using the 6 Laws of Persuasion in Negotiations; The Fine Art of Delegation

6,528,688 relates to an improved Remodulin manufacturing process.

COPYRIGHT 2003 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning

Find Research Guides for:

Find Featured Titles for: Arts

Most Popular Articles in Technology

Most Popular Publications in Technology